BioLife End Period Cash Flow vs Change To Account Receivables Analysis

BLFS Stock

USD 27.06 0.29 1.08%

BioLife Solutions financial indicator trend analysis is way more than just evaluating BioLife Solutions prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioLife Solutions is a good investment. Please check the relationship between BioLife Solutions End Period Cash Flow and its Change To Account Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

End Period Cash Flow vs Change To Account Receivables

End Period Cash Flow vs Change To Account Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioLife Solutions End Period Cash Flow account and Change To Account Receivables. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between BioLife Solutions' End Period Cash Flow and Change To Account Receivables is -0.03. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of BioLife Solutions, assuming nothing else is changed. The correlation between historical values of BioLife Solutions' End Period Cash Flow and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of BioLife Solutions are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of End Period Cash Flow i.e., BioLife Solutions' End Period Cash Flow and Change To Account Receivables go up and down completely randomly.

Correlation Coefficient

-0.03

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Change To Account Receivables

Most indicators from BioLife Solutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 753.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 52.9 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	68.1M	93.7M	117.6M	123.5M
Cost Of Revenue	81.4M	107.9M	96.5M	101.3M

Total Operating Expenses Cost Of Revenue

BioLife Solutions fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Non Current Liabilities Total	Inventory	Net Receivables	Short Long Term Debt Total	Common Stock Total Equity	Short Term Investments	Short Term Debt
Total Assets		1.0	0.98	0.59	0.99	-0.15	-0.79	0.68	0.99	0.99	0.97	0.85	0.95	-0.05	0.98	0.96	0.99	0.96	0.93	0.89	0.93	0.94	0.28	0.18	0.61	0.79
Other Current Liab	1.0		0.98	0.62	0.99	-0.16	-0.78	0.69	0.99	0.98	0.97	0.85	0.95	-0.07	0.97	0.96	0.98	0.96	0.92	0.89	0.93	0.93	0.27	0.18	0.59	0.79
Total Current Liabilities	0.98	0.98		0.52	0.99	0.02	-0.88	0.57	0.97	0.97	0.99	0.79	0.96	-0.08	0.99	0.99	1.0	0.94	0.9	0.93	0.98	0.95	0.31	0.19	0.7	0.87
Total Stockholder Equity	0.59	0.62	0.52		0.51	-0.46	-0.38	0.68	0.61	0.55	0.58	0.52	0.55	-0.03	0.57	0.46	0.51	0.53	0.34	0.37	0.55	0.3	0.1	0.1	-0.19	0.52
Property Plant And Equipment Net	0.99	0.99	0.99	0.51		-0.09	-0.83	0.65	0.98	0.99	0.97	0.85	0.96	-0.09	0.98	0.98	1.0	0.97	0.93	0.92	0.94	0.96	0.3	0.19	0.69	0.81
Net Debt	-0.15	-0.16	0.02	-0.46	-0.09		-0.23	-0.8	-0.1	-0.1	0.02	-0.54	-0.11	-0.29	-0.04	0.09	-0.02	-0.27	-0.04	0.17	0.09	0.06	0.1	0.13	0.3	0.28
Retained Earnings	-0.79	-0.78	-0.88	-0.38	-0.83	-0.23		-0.35	-0.76	-0.8	-0.87	-0.61	-0.9	-0.01	-0.9	-0.87	-0.86	-0.8	-0.64	-0.81	-0.95	-0.79	-0.33	-0.15	-0.75	-0.93
Cash	0.68	0.69	0.57	0.68	0.65	-0.8	-0.35		0.63	0.64	0.57	0.92	0.65	0.14	0.61	0.52	0.6	0.78	0.53	0.45	0.5	0.5	0.1	0.08	0.16	0.32
Non Current Assets Total	0.99	0.99	0.97	0.61	0.98	-0.1	-0.76	0.63		0.98	0.97	0.8	0.93	-0.08	0.96	0.95	0.98	0.93	0.94	0.89	0.92	0.93	0.27	0.18	0.57	0.79
Non Currrent Assets Other	0.99	0.98	0.97	0.55	0.99	-0.1	-0.8	0.64	0.98		0.95	0.82	0.95	-0.07	0.97	0.95	0.98	0.95	0.93	0.88	0.94	0.95	0.25	0.19	0.65	0.77
Other Assets	0.97	0.97	0.99	0.58	0.97	0.02	-0.87	0.57	0.97	0.95		0.77	0.94	-0.11	0.98	0.98	0.98	0.92	0.87	0.92	0.97	0.92	0.32	0.2	0.63	0.9
Cash And Short Term Investments	0.85	0.85	0.79	0.52	0.85	-0.54	-0.61	0.92	0.8	0.82	0.77		0.84	0.11	0.81	0.76	0.82	0.95	0.75	0.69	0.72	0.77	0.2	0.12	0.53	0.53
Common Stock Shares Outstanding	0.95	0.95	0.96	0.55	0.96	-0.11	-0.9	0.65	0.93	0.95	0.94	0.84		0.09	0.98	0.92	0.96	0.96	0.84	0.82	0.96	0.9	0.29	0.08	0.69	0.83
Other Current Assets	-0.05	-0.07	-0.08	-0.03	-0.09	-0.29	-0.01	0.14	-0.08	-0.07	-0.11	0.11	0.09		-0.02	-0.16	-0.09	0.04	-0.06	-0.26	-0.04	-0.03	0.03	-0.31	0.12	-0.18
Other Stockholder Equity	0.98	0.97	0.99	0.57	0.98	-0.04	-0.9	0.61	0.96	0.97	0.98	0.81	0.98	-0.02		0.97	0.99	0.95	0.87	0.89	0.98	0.93	0.31	0.16	0.68	0.88
Total Liab	0.96	0.96	0.99	0.46	0.98	0.09	-0.87	0.52	0.95	0.95	0.98	0.76	0.92	-0.16	0.97		0.98	0.92	0.9	0.98	0.95	0.95	0.3	0.28	0.71	0.88
Property Plant And Equipment Gross	0.99	0.98	1.0	0.51	1.0	-0.02	-0.86	0.6	0.98	0.98	0.98	0.82	0.96	-0.09	0.99	0.98		0.96	0.92	0.93	0.96	0.96	0.31	0.19	0.71	0.85
Total Current Assets	0.96	0.96	0.94	0.53	0.97	-0.27	-0.8	0.78	0.93	0.95	0.92	0.95	0.96	0.04	0.95	0.92	0.96		0.86	0.85	0.9	0.91	0.27	0.16	0.67	0.74
Accounts Payable	0.93	0.92	0.9	0.34	0.93	-0.04	-0.64	0.53	0.94	0.93	0.87	0.75	0.84	-0.06	0.87	0.9	0.92	0.86		0.86	0.8	0.96	0.24	0.14	0.67	0.63
Non Current Liabilities Total	0.89	0.89	0.93	0.37	0.92	0.17	-0.81	0.45	0.89	0.88	0.92	0.69	0.82	-0.26	0.89	0.98	0.93	0.85	0.86		0.88	0.9	0.26	0.37	0.68	0.85
Inventory	0.93	0.93	0.98	0.55	0.94	0.09	-0.95	0.5	0.92	0.94	0.97	0.72	0.96	-0.04	0.98	0.95	0.96	0.9	0.8	0.88		0.89	0.31	0.18	0.69	0.92
Net Receivables	0.94	0.93	0.95	0.3	0.96	0.06	-0.79	0.5	0.93	0.95	0.92	0.77	0.9	-0.03	0.93	0.95	0.96	0.91	0.96	0.9	0.89		0.28	0.15	0.8	0.73
Short Long Term Debt Total	0.28	0.27	0.31	0.1	0.3	0.1	-0.33	0.1	0.27	0.25	0.32	0.2	0.29	0.03	0.31	0.3	0.31	0.27	0.24	0.26	0.31	0.28		-0.08	0.39	0.4
Common Stock Total Equity	0.18	0.18	0.19	0.1	0.19	0.13	-0.15	0.08	0.18	0.19	0.2	0.12	0.08	-0.31	0.16	0.28	0.19	0.16	0.14	0.37	0.18	0.15	-0.08		0.06	0.23
Short Term Investments	0.61	0.59	0.7	-0.19	0.69	0.3	-0.75	0.16	0.57	0.65	0.63	0.53	0.69	0.12	0.68	0.71	0.71	0.67	0.67	0.68	0.69	0.8	0.39	0.06		0.58
Short Term Debt	0.79	0.79	0.87	0.52	0.81	0.28	-0.93	0.32	0.79	0.77	0.9	0.53	0.83	-0.18	0.88	0.88	0.85	0.74	0.63	0.85	0.92	0.73	0.4	0.23	0.58

Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	93.0M	234.8M	552.6M	450.2M	412.7M	433.3M
Other Current Liab	3.5M	9.1M	20.2M	15.7M	15.4M	16.2M
Total Current Liabilities	7.8M	15.6M	40.0M	44.6M	42.2M	44.3M
Total Stockholder Equity	83.0M	205.2M	480.8M	(246.9M)	337.7M	354.5M
Property Plant And Equipment Net	6.6M	19.8M	36.8M	39.2M	32.6M	34.2M
Net Debt	(5.1M)	(79.3M)	(43.0M)	24.3M	7.3M	7.6M
Retained Earnings	(100.1M)	(97.4M)	(105.0M)	(246.9M)	(313.3M)	(297.7M)
Cash	6.4M	90.5M	69.9M	19.4M	35.4M	37.2M
Non Current Assets Total	68.8M	120.1M	426.7M	311.8M	292.1M	306.7M
Non Currrent Assets Other	3.9M	4.7M	9.8M	9.3M	8.0M	8.4M
Other Assets	50K	120.1M	426.7M	386.2M	444.1M	466.3M
Cash And Short Term Investments	6.4M	90.5M	69.9M	64.1M	51.7M	54.3M
Common Stock Shares Outstanding	19.5M	27.3M	38.5M	42.5M	43.7M	45.9M
Liabilities And Stockholders Equity	93.0M	234.8M	552.6M	(160.9M)	412.7M	433.3M
Other Current Assets	13.1M	4.7M	4.7M	6.9M	6.8M	3.6M
Other Stockholder Equity	183.1M	302.6M	585.4M	611.7M	651.3M	683.9M
Total Liab	10.0M	29.6M	71.9M	86.0M	75.1M	78.8M
Property Plant And Equipment Gross	6.6M	19.8M	43.5M	48.4M	42.1M	44.2M
Total Current Assets	24.2M	114.7M	125.9M	138.5M	120.6M	126.6M
Accounts Payable	3.1M	3.7M	14.9M	15.4M	6.9M	7.3M
Non Current Liabilities Total	2.2M	14.0M	31.9M	41.5M	32.9M	34.5M
Inventory	11.1M	11.6M	28.3M	34.9M	43.5M	45.6M
Net Receivables	5.3M	8.0M	23.2M	33.9M	18.7M	19.6M
Common Stock Total Equity	14.0K	19K	21K	33K	38.0K	35.1K
Common Stock	21K	33K	42K	43K	45K	36.6K
Property Plant Equipment	1.3M	5.6M	24.5M	46.6M	53.6M	56.3M
Other Liab	41.1M	14.0M	31.9M	2.6M	3.0M	2.8M
Net Tangible Assets	(12.2M)	205.2M	480.8M	364.2M	418.8M	439.8M
Retained Earnings Total Equity	(74.0M)	(71.0M)	(100.1M)	(97.4M)	(87.6M)	(92.0M)
Capital Surpluse	84.0M	114.2M	143.5M	302.6M	348.0M	365.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC